• 1. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 2. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 3. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid esters
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid derivatives Carboxylic acid esters

Recent Advances in the Study of 2-Methylbutyl Isobutyrate (CAS: 2445-69-4) in Chemical Biology and Pharmaceutical Research

2-Methylbutyl isobutyrate (CAS: 2445-69-4) is a volatile ester compound that has garnered significant attention in recent years due to its diverse applications in the chemical, biological, and pharmaceutical fields. This compound, characterized by its fruity aroma, is not only used as a flavoring agent but also exhibits potential pharmacological properties. Recent studies have explored its role in drug formulation, antimicrobial activity, and even as a biomarker in metabolic studies. This research brief aims to synthesize the latest findings on 2-Methylbutyl isobutyrate, providing a comprehensive overview of its current applications and future prospects.

One of the most notable advancements in the study of 2-Methylbutyl isobutyrate is its potential as an antimicrobial agent. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits significant inhibitory effects against a range of Gram-positive and Gram-negative bacteria, including Staphylococcus aureus and Escherichia coli. The researchers attributed this activity to the compound's ability to disrupt bacterial cell membranes, suggesting its potential as a novel antibiotic scaffold. Further in vivo studies are underway to evaluate its efficacy and safety in clinical settings.

In addition to its antimicrobial properties, 2-Methylbutyl isobutyrate has been investigated for its role in drug delivery systems. A recent study in the International Journal of Pharmaceutics highlighted its use as a permeation enhancer in transdermal drug delivery. The study found that the compound significantly improved the absorption of hydrophobic drugs through the skin, making it a promising candidate for enhancing the bioavailability of topical formulations. This finding opens new avenues for the development of more effective transdermal therapies.

Another emerging area of research involves the use of 2-Methylbutyl isobutyrate as a biomarker in metabolic disorders. A 2024 study published in Metabolomics identified this compound as a potential indicator of metabolic dysregulation in patients with type 2 diabetes. The study utilized advanced mass spectrometry techniques to correlate elevated levels of 2-Methylbutyl isobutyrate with insulin resistance, suggesting its utility in early diagnosis and monitoring of metabolic diseases. This discovery could pave the way for non-invasive diagnostic tools.

Despite these promising findings, challenges remain in the large-scale production and application of 2-Methylbutyl isobutyrate. Current synthetic methods often yield low quantities, and the compound's stability under various conditions needs further investigation. However, recent advances in biocatalysis and green chemistry offer potential solutions. For instance, a 2023 study in Biotechnology Advances reported the use of engineered enzymes to produce 2-Methylbutyl isobutyrate with higher efficiency and sustainability, addressing some of these limitations.

In conclusion, 2-Methylbutyl isobutyrate (CAS: 2445-69-4) represents a versatile compound with significant potential in chemical biology and pharmaceutical research. Its antimicrobial activity, role in drug delivery, and utility as a metabolic biomarker highlight its multifaceted applications. Future research should focus on optimizing production methods, exploring its mechanistic pathways, and translating these findings into clinical applications. As the scientific community continues to uncover its potential, 2-Methylbutyl isobutyrate is poised to play a pivotal role in advancing both basic and applied research in the life sciences.

• 2050-01-3(Isoamyl Isobutyrate)
• 2445-67-2(Butanoic acid,2-methyl-, 2-methylpropyl ester)
• 35061-61-1(Propanoic acid,2-methyl-, 2-ethylhexyl ester)
• 37064-20-3(Propyl 2-methylbutanoate)
• 10307-61-6((2S)-2-Methyl-butanoic Acid Ethyl Ester)
• 7452-79-1(Ethyl 2-methylbutyrate)
• 2445-78-5(2-methylbutyl 2-methylbutyrate)
• 27625-35-0(3-Methylbutyl 2-methylbutanoate)
• 81115-67-5((S)-(S)-2-Methylbutyl 2-methylbutanoate)
• 35852-44-9(Propanoic acid,2-methyl-, 4-methylpentyl ester)